Osteopontin Protein, a New Way to Improve Treatments in Breast Cancer
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.5 Articles
5 Articles
laprovincia.es
The Clinical Breast Cancer Research Unit of the National Cancer Research Center (CNIO) has identified in mice a new target involved in cancer, the osteopontin protein. The new result opens a pathway to, blocking this target, expand the effectiveness of antiangiogenic treatments, medicines that prevent the creation of new blood vessels (angiogenesis) that tumors need to nourish and grow. Acting against osteopontin would also contribute to enhanci…
The Clinical Breast Cancer Research Unit of the National Center for Oncological Research (CNIO) has identified in mice a new target involved in cancer, the osteopontin protein. The new result opens a pathway to, blocking this target, increasing the effectiveness of antiangiogenic treatments. Acting against osteopontin would also contribute to enhancing [...] The entry New way to improve the effectiveness of antiangiogenics and immunotherapy in b…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
